US FDA approves ImmunityBio’s bladder cancer therapy
The U.S. health regulator approved on Monday ImmunityBio’s combination therapy to treat a type of bladder cancer, marking an end to the company’s efforts to bring its therapy to the market.
The U.S. health regulator approved on Monday ImmunityBio’s combination therapy to treat a type of bladder cancer, marking an end to the company’s efforts to bring its therapy to the market.
Oncologists tackle angiosarcoma of the breast with an intensive regimen of daily radiation.
Hypertension can be a silent killer. Learn what doctors wish patients knew about which changes to make to lower BP and why they matter.
A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced.
With tens of thousands of Americans already affected by enrollment scams that leave some without doctors or treatments, Oregon Sen. Ron Wyden wants increased enforcement…
Optum Rx is rolling out a new pharmacy model that seeks to make drug costs more predictable and transparent for clients. | Optum Rx is…
The copycats are possible because of drug shortages.
The new Surface Laptop is a true MacBook Air killer in performance, battery life, and looks.
Alphabet’s Google has preemptively paid damages to the U.S. government, an unusual move aimed at avoiding a jury trial in the Justice Department’s blockbuster antitrust…
Employers are in a unique position to drive change in obesity care, but face several challenges. Experts shared numerous strategies employers can implement.
A new coalition called Tech Against Scams is bringing companies together to fight online fraud.